Investor summary

Premium menopause intelligence for modern provider organizations

Pause-Health.ai transforms fragmented menopause care into an elegant, measurable, and clinically explainable workflow built for provider excellence.

• Focus cohort: women ages 40-60 navigating perimenopause and menopause with nuanced, evolving symptom profiles.
• 67% are initially misdiagnosed; the average path to accurate diagnosis can extend to 2.5 years.
• Pause target: 89% AI-assisted triage accuracy with transparent, evidence-linked rationale.
• FHIR-native data and wearable biomarkers create a real-time menopause intelligence layer.
• Commercial strategy: provider-first B2B model delivering measurable ROI and durable ARR growth.